COMPASS Pathways (CMPS)
NASDAQ: CMPS
· Real-Time Price · USD
6.83
-0.01 (-0.15%)
At close: Oct 15, 2025, 3:59 PM
6.84
0.15%
After-hours: Oct 15, 2025, 04:17 PM EDT
-0.15% (1D)
| Bid | 6.83 |
| Market Cap | 639.19M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -138.56M |
| EPS (ttm) | -1.81 |
| PE Ratio (ttm) | -3.77 |
| Forward PE | -4.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 7.09 |
| Volume | 1,677,343 |
| Avg. Volume (20D) | 1,867,490 |
| Open | 6.98 |
| Previous Close | 6.84 |
| Day's Range | 6.63 - 7.03 |
| 52-Week Range | 2.25 - 7.08 |
| Beta | 2.22 |
| Ex-Dividend Date | n/a |
About CMPS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-0.65%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
2 months ago
+3.72%
Shares of psychedelic companies are trading higher following a report suggesting California Governor Newsom said he is "all in" on expanding access to psychedelics for therapeutic use.
2 months ago · fool.com
Compass (CMPS) Q2 Loss Improves 27%Compass (CMPS) Q2 Loss Improves 27%
2 months ago · businesswire.com
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal...
